Systemic therapy in hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Systemic therapy in hepatocellular carcinoma.

Systemic therapy in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37135733

about

Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish Inhibitory effects of nobiletin on hepatocellular carcinoma in vitro and in vivo.Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel.Liver diseases: what is known so far about the therapy with human amniotic membrane?An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma.Therapeutic strategies for hepatocellular carcinoma: new advances and challenges.A novel therapeutic combination sequentially targeting aurora B and Bcl-xL in hepatocellular carcinoma.When good transforming growth factor-β turns bad in hepatocellular carcinoma: Axl takes the stage.

P2860

Q27310913-CD380B9D-4501-47D2-9EAF-D78367FD4367 Q34789103-A859DBB8-52E5-474B-A738-44F254C72400 Q35491733-9760ADFA-1F7F-46D3-93C3-C0495F59CD24 Q37317180-6EE67A2D-103D-47E7-9F95-BDAB8604AFA7 Q38798897-0DBD5623-77F6-4540-B760-925B3F883309 Q38934348-92E26BD8-7BC7-4393-AF93-A3E9B11F329E Q41134603-B012688D-BFED-4EA7-A38F-CB7F7307CCE4 Q41191439-CF4B9607-9E5E-487B-B215-04A9DBDF9848 Q53664285-49723954-8AEB-424D-86D9-DAE365F0817D Q55070013-7677FED4-D46C-4B55-8486-1E85BE89278F

P2860

Systemic therapy in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37135733

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Systemic therapy in hepatocellular carcinoma.

@en

Systemic therapy in hepatocellular carcinoma.

@nl

type

label

Systemic therapy in hepatocellular carcinoma.

@en

Systemic therapy in hepatocellular carcinoma.

@nl

prefLabel

Systemic therapy in hepatocellular carcinoma.

@en

Systemic therapy in hepatocellular carcinoma.

@nl

P1433

Q37135733-50780E6C-1D34-4DDC-993A-D0D623E44CC5

P1476

Q37135733-41140BDB-4E61-4AB4-B8EB-1859C0B1FCC5

P2093

Q37135733-2DB05BA3-EA10-4B7F-B435-772D38F1584A

Q37135733-2FBB6A16-7298-44D6-9F1A-78637502B4F7

Q37135733-A6BFE35C-0D97-4D65-82ED-D21564CE784A

P2860

Q37135733-00016CE9-1552-4D06-A2E1-E59E5DF8E7FB

Q37135733-09F7C2C4-1DFC-4A2B-BA49-402F9A50F104

Q37135733-0CC8DC49-01CC-4752-A0F1-105307F28E22

Q37135733-13B78631-D02D-4899-824B-0EBE358E762E

Q37135733-1AF615A9-DAC1-4AB8-A1EC-2754B2E23E74

Q37135733-1D8B9CFF-1367-4B14-A5C7-BEAC218ECF71

Q37135733-227CDED0-3242-478C-AE11-F95465C62A1B

Q37135733-2FD71B99-E0F6-49CB-9D51-3DC8FB5FE97B

Q37135733-354E6AE6-3BCA-4A60-BB40-EB6AA1CC3F03

Q37135733-3DC8C8ED-AE6D-492B-993B-7DC1521440FA

P304

Q37135733-AAF942E0-6BBE-4EA1-A001-03D154339841

P31

Q37135733-5C5D7D2B-A61F-40B8-86A3-9493716A586D

P356

Q37135733-7CECB8C4-191E-4331-8641-489F06A45245

P433

Q37135733-EAC869C9-1057-4852-A194-770CEED3BB07

P478

Q37135733-33D7C249-A940-479B-8754-3A12F71A2AB9

P577

Q37135733-A36C0453-D001-457E-99DA-28F6A4AB8F8C

P5875

Q37135733-FA4C9D59-0179-44DD-B869-B5BEB994D85E

P698

Q37135733-88CABE5C-D178-408F-9386-B9EC0E5AC581

P932

Q37135733-D0D705CD-F210-4CC5-9DCB-2B64EC0387CE

P356

J.CLD.2011.03.002

P1433

Clinics in liver disease

P1476

Systemic therapy in hepatocellular carcinoma.

@en

P2093

Mario Strazzabosco

http://www.w3.org/2001/XMLSchema#string

Stephen H Wrzesinski

http://www.w3.org/2001/XMLSchema#string

Tamar H Taddei

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Primary liver cancer: worldwide incidence and trends

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study.

Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.

P304

423-41, vii-x

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLD.2011.03.002

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51234962

http://www.w3.org/2001/XMLSchema#string

P698

21689622

http://www.w3.org/2001/XMLSchema#string

P932

3758582

http://www.w3.org/2001/XMLSchema#string